A standard nonmyeloablative transplant regimen for adults with sickle cell disease - are we there yet?: Commentary on Saraf SL, Oh AL et al, “Nonmyeloablative stem cell transplantation with alemtuzumab/low-dose irradiation to cure and improve the quality of life of adults with sickle cell disease”

Lignende værker

• Transfusion-Associated Babesiosis with an Atypical Time Course after Nonmyeloablative Transplantation for Sickle Cell Disease
  af: Cirino, Christopher M., et al.
  Udgivet: (2008)
• Autoimmune Thyroid Disease Following Alemtuzumab Therapy and Hematopoietic Cell Transplantation in Pediatric Patients with Sickle Cell Disease
  af: Williams, Kristen M, et al.
  Udgivet: (2014)
• Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease
  af: Saraf, Santosh L., et al.
  Udgivet: (2019)
• Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype
  af: Hsieh, Matthew M., et al.
  Udgivet: (2014)
• Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions
  af: Özdoğu, Hakan, et al.
  Udgivet: (2015)